For the Inventor, By the Inventor

Enter assignee name

Vancouver, Canada

British Columbia Cancer Agency Branch

USPTO Granted Patents = 65

CIPO Patents = 8

EPO Patents = 31

Forward Citations = 289

Loading Chart...

Loading Chart...

193 inventors (with patents filed for the assignee):

Raymond John Andersen (14 out of 42 patents)

Marianne Dorothy Sadar (13 out of 18 patents)

Nasrin R Mawji (12 out of 14 patents)

4. Joseph M Connors (10 out of 10 patents)

5. Carmen Adriana Banuelos (9 out of 10 patents)

6. Randy D Gascoyne (8 out of 8 patents)

7. Erlend B Smeland (6 out of 7 patents)

8. Elaine S Jaffe (6 out of 7 patents)

9. Louis M Staudt (6 out of 9 patents)

10. German Ott (6 out of 6 patents)

11. David Thomas Stinson (5 out of 39 patents)

12. Robin John Noel Coope (5 out of 10 patents)

13. Javier Garcia Fernandez (5 out of 5 patents)

14. Lisa M Rimsza (5 out of 6 patents)

15. Wing C Chan (5 out of 6 patents)

Core Competencies:

Intramedullary Fixation

Lymphoma Subtyping

Cancer Imaging

Biomarkers for Lymphomas

Androgen Receptor Modulators

Optical Imaging Systems

Chronic Obstructive Pulmonary Disease

Tumor-Promoting Genes

Epigenetic Defects in Cancer

Viral Gene Transfer

Breast Cancer Treatment

Nucleic Acid Selection

65 patents: Sort by Forward Citations

1. 12167877 - Shape adaptable intramedullary fixation device (2024-12-17),

2. 12023074 - Systems and methods for intermedullary bone fixation (2024-07-02),

3. 11779550 - Bisphenol ether derivatives and methods for using the same (2023-10-10),

4. 11725248 - Evaluation of mantle cell lymphoma and methods related thereto (2023-08-15),

5. 11574704 - Method for subtyping lymphoma types by means of expression profiling (2023-02-07),

6. 11529148 - Intramedullary fixation system for management of pelvic and acetabular fractures (2022-12-20),

7. 11419645 - Intramedullary fixation device with shape locking interface (2022-08-23),

8. 11345670 - Heterocyclic compounds for cancer imaging and treatment and methods for their use (2022-05-31),

9. 11326212 - Biomarkers for non-hodgkin lymphomas and uses thereof (2022-05-10),

10. 11028444 - Survival predictor for diffuse large B cell lymphoma (2021-06-08),

11. 10973559 - Systems and methods for intermedullary bone fixation (2021-04-13),

12. 10941209 - Identification and use of new tumor-promoting gene in hematological malignancies (2021-03-09),

13. 10882871 - 18/19F-labelled compounds which target the prostate specific membrane antigen (2021-01-05),

14. 10697975 - Methods for identifying, diagnosing, and predicting survival of lymphomas (2020-06-30),

15. 10654811 - Heterocyclic compounds for cancer imaging and treatment and methods for their use (2020-05-19),

The British Columbia Cancer Agency (BCCA) is committed to reducing the impact of cancer on the people of British Columbia by providing excellence in cancer care, research, and education. With multiple branches across the province, the BCCA offers comprehensive cancer control programs and services, including prevention, early detection, treatment, and support. Their website provides access to a wide range of resources, including information on different cancer types, treatment options, clinical trials, and supportive care. Through their innovative research initiatives, the BCCA aims to advance knowledge and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

65 Patents

#8 in Vancouver

#195 in Canada

#11,033 in the World

Vancouver, Canada

British Columbia Cancer Agency Branch

Forward Citations = 289

193 inventors:

Raymond John Andersen (14 out of 42 patents)

Marianne Dorothy Sadar (13 out of 18 patents)

Nasrin R Mawji (12 out of 14 patents)

4. Joseph M Connors (10 out of 10 patents)

5. Carmen Adriana Banuelos (9 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…